DSTYK and breast carcinoma: Statistical analysis of the patient dataset indicates that a high DSTYK level is correlated with a high probability of death in breast cancer patients (Figure 1A, The Human Protein Atlas), TNBC patients (Figure 1B, Kaplan-Meier Plotter), and TNBC patients treated with chemotherapy only (Figure 1C, Kaplan-Meier Plotter).